The Almac Group is an established contract development and manufacturing organisation that provides an extensive range of integrated services globally to companies within the pharmaceutical and biotech sectors.  The services range from R&D, biomarker discovery, API manufacture, formulation and analytical development, clinical trial supply, IRT technology through to product launch, commercial drug product manufacture and packaging.

Only Almac can combine the expertise, from our specialised teams, to provide you with the right service solutions to help you across the full biopharmaceutical product lifecycle, from development through to commercialisation.

We are a privately owned organisation that has organically grown over 50 years and now employs in excess of 5,000 high skilled personnel.  Almac is headquartered in Craigavon, Northern Ireland with 17 global facilities in the UK, Ireland, across the US (Pennsylvania, North Carolina and California) and in Asia (Singapore and Tokyo).

Through our continual investment in the expansion of our state of the art services; from new world-class, 220,000ft2 pharmaceutical development facilities complete with dedicated high potency processing suites through to specialised packaging solutions supporting complex kit assembly and serialisation, Almac ensures we are always there to support you across the product development lifecycle.

Almac – A Unique Culture Delivering Exceptional Solutions
Brexit – A Seamless Solution


Almac’s experienced formulation scientists can develop a range of oral dose formulations for early stage clinical trials.

Specialising in solid oral dosage forms, Almac has the technical experience and knowledge to develop robust formulations and manufacturing processes.

Scaling up from our development services to full scale commercial drug product manufacture or transferring existing commercial products we can meet your commercial drug product manufacturing requirements.

We offer a wide range of commercial packaging solutions to meet your needs, from initial artwork and pack design, to commercial packaging and distribution.

Having successfully partnered in the launch of 15 significant orphan and niche drug products into the EU market over the last 3 years, Almac is the industry leader for Pharmaceutical Product Launch and Distribution.

Addressing evolving global serialization legislation, Almac’s expert multi-disciplinary serialization team lead the way in supporting clients in developing their serialization strategies to GS1 standards.

Complementing our commercial manufacturing and packaging services, we provide a range of commercial storage and distribution solutions for solid oral dosage forms and sterile biopharmaceuticals, for both niche / orphan drug products and large scale commercial market volumes.


Almac Group

2661 Audubon Road

Audubon, PA 19403


Phone: 610 666 9500

Fax: 610 666 8551

Contact: Adam Schroeder